The landscape of tobacco consumption in India is undergoing a profound shift as regulatory pressures and shifting consumer habits carve a divergent path for different sectors of the industry. While the central government has intensified its campaign against traditional cigarettes through steep taxation and stringent packaging requirements, the vast and fragmented market for smokeless tobacco products continues to operate with surprising resilience. This trend is creating a complex public health challenge for a nation that already grapples with some of the highest rates of oral cancer in the world.
For years, global health organizations have focused their attention on the visible smoke of factory-made cigarettes. In response, Indian authorities have implemented one of the world’s most aggressive anti-smoking frameworks. Cigarettes are now subject to the highest tier of the Goods and Services Tax, and every pack sold must display graphic health warnings that cover the majority of the surface area. These measures have successfully deterred many urban youth from picking up the habit and have pushed premium cigarette manufacturers into a defensive posture, forcing them to justify their value propositions to a more health-conscious demographic.
However, the story of smokeless tobacco is markedly different. Products such as khaini, gutka, and various forms of scented zarda remain deeply embedded in the cultural fabric of rural and semi-urban India. Unlike cigarettes, which are often produced by a few large corporations with transparent supply chains, the smokeless tobacco industry is characterized by thousands of small-scale, decentralized manufacturing units. This fragmentation makes it exceptionally difficult for tax authorities to enforce revenue collection or for health inspectors to ensure that products meet safety standards. Consequently, while cigarette prices have climbed steadily, smokeless alternatives remain remarkably affordable for the average laborer. 
Economic analysts point out that the price elasticity of tobacco in India is skewed by these alternatives. When the cost of a pack of cigarettes rises beyond a certain threshold, a significant portion of the consumer base does not quit tobacco altogether. Instead, they migrate toward cheaper, non-combustible products. This substitution effect undermines the primary goal of high taxation, which is to reduce overall tobacco prevalence. The persistent popularity of these products is bolstered by their ease of use in workplaces where smoking is prohibited, allowing users to maintain a nicotine habit discreetly throughout the day.
Public health experts are increasingly vocal about the dangers of this regulatory gap. The chemical composition of many Indian smokeless tobacco products is notoriously unregulated, often containing high levels of heavy metals and alkaline agents that accelerate nicotine absorption. Because these products are placed directly against the buccal mucosa for extended periods, they pose a more direct threat of oral malignancies than inhaled smoke. Despite various state-level bans on flavored chewing tobacco, enforcement remains inconsistent, and products are often sold in split sachets to bypass legal restrictions.
The challenge for Indian policymakers moving forward will be to harmonize the regulation of all tobacco types. Relying solely on cigarette taxation creates a lopsided market where the most hazardous, unrefined products become the most accessible. There is a growing consensus that a holistic approach is required—one that combines strict supply-side controls on raw tobacco leaves with more effective grassroots education campaigns. Until the regulatory net is widened to capture the smokeless sector with the same rigor applied to cigarettes, the country’s tobacco epidemic will likely continue to evolve rather than disappear.
As the industry matures, the financial stakes are also rising. While major players in the cigarette space are pivoting toward heat-not-burn technology and other harm-reduction tools, the traditional smokeless market remains stuck in a cycle of low-cost production and high-volume sales. The ability of the Indian government to pivot its strategy will determine whether the next decade sees a genuine decline in tobacco-related illness or merely a change in the way the population consumes its nicotine.
